Investigating how cannabis affects inflammation and insulin sensitivity
Exploring the anti-inflammatory properties of cannabis and their relevance to insulin sensitivity
This study is looking at how using cannabis might help with inflammation and insulin sensitivity, which could be important for people with type 2 diabetes, by checking how different compounds in cannabis affect metabolism and body weight.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado NIH-funded |
| Lab location | 1 site (Boulder, UNITED STATES) |
| Project ID | NIH-10619625 on NIH RePORTER |
What this research studies
This research explores the relationship between cannabis use and its potential anti-inflammatory effects, particularly in relation to insulin sensitivity and type 2 diabetes. The study examines how different cannabinoids, such as THC and CBD, may influence inflammatory markers and metabolic processes. By analyzing the effects of cannabis on body weight and caloric intake, the research aims to clarify the complex interactions between cannabis use and metabolic health. Participants may be involved in assessments that measure their insulin sensitivity and inflammatory responses to cannabis consumption.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults who use cannabis and are at risk for or currently managing type 2 diabetes.
Not a fit: Patients who do not use cannabis or those without metabolic health issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights on how cannabis might be used to improve metabolic health and manage conditions like type 2 diabetes.
How similar studies have performed: While there is some preliminary evidence suggesting cannabis may have beneficial effects on metabolic health, this specific approach is relatively novel and has not been extensively tested.
Where this research is happening
Boulder, UNITED STATES
- University of Colorado — Boulder, United States (Active)
Researchers
- Principal investigator: Bryan, Angela — University of Colorado
- Study coordinator: Bryan, Angela
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.